Is There an Increased Risk of Second Primary Malignancy After Diagnosis of Thyroid Cancer?

被引：2
作者：
Mathur, Aarti [1 ]
Schneider, Eric B. [1 ]
Zeiger, Martha A. [1 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA
来源：
CANCER | 2015年 / 121卷 / 02期
关键词：
RADIOACTIVE IODINE; CARCINOMA;
D O I：
10.1002/cncr.29026
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Recent reports on the risk of developing second primary malignancies have raised concern about whether enhanced surveillance is warranted in patients with thyroid cancer. An excellent review of the incidences and types of second primary malignancies in a Korean population treated for thyroid cancer is provided in this issue of Cancer.
引用
收藏
页码：166 / 168
页数：3
相关论文
共 50 条
  • [31] The relationship of thyroid nodule size on malignancy risk according to histological type of thyroid cancer
    Chung, Sae Rom
    Baek, Jung Hwan
    Choi, Young Jun
    Sung, Tae-Yon
    Song, Dong Eun
    Kim, Tae Yong
    Lee, Jeong Hyun
    ACTA RADIOLOGICA, 2020, 61 (05) : 620 - 628
  • [32] The risk of secondary primary malignancy in early stage differentiated thyroid cancer: a US population-based study
    Uprety, Dipesh
    Khanal, Amit
    Arjyal, Lubina
    Bista, Amir
    Basnet, Bibhusan
    Kandel, Pujan
    Gogireddy, Thulasi Ram
    Adhikari, Janak
    ACTA ONCOLOGICA, 2016, 55 (11) : 1375 - 1377
  • [33] Risk of second primary malignancies after definitive treatment for esophageal cancer: A competing risk analysis
    Mitani, Seiichiro
    Kadowaki, Shigenori
    Oze, Isao
    Masuishi, Toshiki
    Narita, Yukiya
    Bando, Hideaki
    Oonishi, Sachiyo
    Hirayama, Yutaka
    Tanaka, Tsutomu
    Tajika, Masahiro
    Koide, Yutaro
    Kodaira, Takeshi
    Abe, Tetsuya
    Muro, Kei
    CANCER MEDICINE, 2020, 9 (01): : 394 - 400
  • [34] Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?
    Wu, Geena X.
    Nelson, Rebecca A.
    Kim, Jae Y.
    Raz, Dan J.
    CLINICAL LUNG CANCER, 2017, 18 (05) : 543 - +
  • [35] Trends in Imaging After Diagnosis of Thyroid Cancer
    Wiebel, Jaime L.
    Banerjee, Mousumi
    Muenz, Daniel G.
    Worden, Francis P.
    Haymart, Megan R.
    CANCER, 2015, 121 (09) : 1387 - 1394
  • [36] Age-related risk for second breast cancer and gynecological malignant neoplasms after differentiated thyroid cancer
    Zhao, Xianlan
    Yang, Guangrong
    Zhang, Weina
    Dong, Qiang
    Yang, Qiao
    ENDOCRINE, 2022, 76 (02) : 385 - 394
  • [37] Thyroid malignancy risk in different clinical thyroid diseases
    Dirikoc, Ahmet
    Faki, Sevgul
    Baser, Husniye
    Ozdemir, Didem
    Aydin, Cevdet
    Ersoy, Reyhan
    Kilic, Mehmet
    Kilicarslan, Aydan
    Cakir, Bekir
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2017, 47 (05) : 1509 - 1519
  • [38] Effect of external beam radiotherapy on second primary cancer risk after radical prostatectomy
    Preisser, Felix
    Mazzone, Elio
    Knipper, Sophie
    Nazzani, Sebastiano
    Bandini, Marco
    Shariat, Shahrokh F.
    Marchioni, Michele
    Tian, Zhe
    Saad, Fred
    Taussky, Daniel
    Briganti, Alberto
    Huland, Hartwig
    Graefen, Markus
    Tilki, Derya
    Karakiewicz, Pierre, I
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2020, 14 (05): : E173 - E179
  • [39] Is radioactive iodine-131 treatment related to the occurrence of non-synchronous second primary malignancy in patients with differentiated thyroid cancer?
    de Souza, Marcelo Cruzick
    Momesso, Denise P.
    Vaisman, Fernanda
    Neto, Leonardo Vieira
    Gomes Martins, Rosangela Aparecida
    Corbo, Rossana
    Vaisman, Mario
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2016, 60 (01): : 9 - 15
  • [40] Competing mortality risk from second primary malignancy in bladder cancer patients following radical cystectomy: Implications for survivorship
    Hensley, Patrick J.
    Duan, Zhigang
    Bree, Kelly
    Sood, Akshay
    Zhao, Hui
    Lobo, Niyati
    Contieri, Roberto
    Campbell, Matthew T.
    Guo, Charles C.
    Navai, Neema
    Williams, Stephen B.
    Dinney, Colin P.
    Kamat, Ashish M.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (02) : 108e11 - 108e17
12345